share_log

National Health Investors (NYSE:NHI) Given New $61.00 Price Target at Truist Financial

Defense World ·  Sep 27, 2022 03:22

National Health Investors (NYSE:NHI – Get Rating) had its price objective reduced by Truist Financial from $64.00 to $61.00 in a research report sent to investors on Monday, The Fly reports. They currently have a hold rating on the real estate investment trust's stock.

Several other analysts have also weighed in on the stock. Capital One Financial started coverage on shares of National Health Investors in a research report on Friday, June 3rd. They set an overweight rating and a $64.00 target price on the stock. Credit Suisse Group began coverage on shares of National Health Investors in a report on Wednesday, June 22nd. They set an underperform rating for the company. Finally, BMO Capital Markets downgraded shares of National Health Investors from an outperform rating to a market perform rating and set a $62.00 price target for the company. in a report on Tuesday, June 21st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of Hold and an average price target of $59.50.

Get National Health Investors alerts:

National Health Investors Price Performance

Shares of National Health Investors stock opened at $56.40 on Monday. The company has a debt-to-equity ratio of 0.79, a quick ratio of 12.92 and a current ratio of 12.92. The firm's 50-day simple moving average is $64.12 and its 200-day simple moving average is $59.94. National Health Investors has a twelve month low of $50.22 and a twelve month high of $67.16. The firm has a market cap of $2.52 billion, a P/E ratio of 38.63 and a beta of 0.86.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 4th. Investors of record on Friday, September 30th will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 6.38%. The ex-dividend date is Thursday, September 29th. National Health Investors's dividend payout ratio is currently 246.58%.

Insiders Place Their Bets

In related news, Director Robert G. Adams bought 1,500 shares of the company's stock in a transaction on Monday, August 15th. The stock was bought at an average cost of $65.93 per share, with a total value of $98,895.00. Following the completion of the purchase, the director now owns 85,411 shares in the company, valued at approximately $5,631,147.23. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 7.26% of the company's stock.

Hedge Funds Weigh In On National Health Investors

Institutional investors have recently modified their holdings of the stock. EverSource Wealth Advisors LLC raised its stake in shares of National Health Investors by 1,177.1% in the second quarter. EverSource Wealth Advisors LLC now owns 447 shares of the real estate investment trust's stock worth $27,000 after acquiring an additional 412 shares during the last quarter. Quadrant Capital Group LLC raised its stake in shares of National Health Investors by 79.4% during the second quarter. Quadrant Capital Group LLC now owns 470 shares of the real estate investment trust's stock worth $29,000 after buying an additional 208 shares during the last quarter. Assetmark Inc. raised its stake in shares of National Health Investors by 400.0% during the second quarter. Assetmark Inc. now owns 500 shares of the real estate investment trust's stock worth $30,000 after buying an additional 400 shares during the last quarter. TCI Wealth Advisors Inc. raised its stake in shares of National Health Investors by 566.0% during the first quarter. TCI Wealth Advisors Inc. now owns 706 shares of the real estate investment trust's stock worth $42,000 after buying an additional 600 shares during the last quarter. Finally, Financial Advantage Inc. bought a new stake in shares of National Health Investors during the first quarter worth approximately $59,000. 65.25% of the stock is owned by institutional investors.

About National Health Investors

(Get Rating)

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Read More

  • Get a free copy of the StockNews.com research report on National Health Investors (NHI)
  • MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
  • Is the Market Overreacting with Shopify Stock?
  • MO Money: Why Altria Group Stock is Rallying
  • Fed Raises Rates: 3 Stocks to Watch Newmont Mining, Walmart, AMC
  • Three Consumer Stocks That Could Outperform In Q4

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment